Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Apeiron acquires rights to hu14.18-IL2 from Merck KGaA

Feb. 4, 2011

FDA awards EGEN grant for phase II EGEN-001 development in ovarian cancer

Feb. 4, 2011

Marina Biotech and Debiopharm partner for RNAi-based bladder cancer therapy

Feb. 4, 2011

Smac mimetic JP-1201 enhances response to chemotherapy in models of pancreatic ductal carcinoma

Feb. 4, 2011

New inhibitors claimed of RAC-alpha serine/threonine-protein kinase phosphorylation

Feb. 3, 2011

Enrollment started in Aveo Pharma's phase II tivozanib biomarker trial

Feb. 3, 2011

ELGEN-1000-delivered DNA vaccines cleared to enter phase II leukemia trial in U.K.

Feb. 3, 2011

Novel protein kinase inhibitors described at sanofi-aventis

Feb. 3, 2011

Enrollment begins in phase II CP-4126 trial in gemcitabine-refractory pancreatic cancer

Feb. 2, 2011

Hutchison MediPharma begins phase I trial of fruquintinib in China

Feb. 2, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026